Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer&#39;s disease.

Leqembi (lecanemab-irmb) - Biogen, Eisai

http://www.ncbi.nlm.nih.gov/pubmed/42712875

Chang Uk Lee; Dong Woo Kang; Gihwan Byeon; Hyun Kook Lim; Ilah Shin; Jinhee Jang; Jung-Won Lee; Seunggyun Ha; Sheng-Min Wang; Sonya Youngju Park; Suhyung Kim; Yoo Hyun Um

Sep 10, 2026